Jiangsu Jubang Pharmaceutical Co., Ltd.
The company is located at No. 1 Kang'an Road, Liyang Economic Development Zone, Jiangsu Province. The factory covers an area of about 60,000 square metres. There are no pollution sources around the factory. The ground, pavement and transportation of the factory do not pollute the production of drugs. The overall layout is reasonable, and the supporting facilities for various public works are complete. The company has a registered capital of 40 million yuan and a total assets of 180 million yuan.
In 2009, Jiangsu Jubang Pharmaceutical Co., Ltd. began production. Its main products include APIs (vitamin B1, mesalazine) and food additives (sucrose). The annual production capacity is 200 tons of mesalazine APIs, 100 tons of vitamin B1 APIs, and 500 tons of sucrose food additives.
In 2020, in response to the government's call to fight the COVID-19 epidemic, enterprises launched a new project of 1,000 tons/year of 75% ethanol wash-free disinfection gels and 100 tons/year sodium hypochlorite disinfectant.
Integrity Management, Careful Manufacturing
The company pays great attention to product quality testing and scientific research and development. It has built a new modern scientific research building of more than 3,000 square metres, with a series of advanced testing equipment and a mature quality management system to ensure accurate testing and comprehensive control of product quality.
Jubang people implement the quality policy of "honest management, meticulous manufacturing; standardise product safety management, strictly control all production links; continue to improve, constantly innovate, and provide customers with high-quality products", adhere to the concept of "serving the cause of human health", and adhere to the "remitting spirit of self-improvement and worry about danger. The moral concept of consciousness, morality and people-oriented code of conduct continue to explore the field of medical raw materials and health care raw materials. We are committed to scientific and technological innovation with high starting point and high technology as the starting point, strive to be a qualified enterprise citizen, become an international enterprise for sustainable development in the field of health industry, and for society. Human beings provide excellent drugs to serve health.
Twenty years of rich experience and control ability in entrepreneurship and continuous operation have established a stable, efficient and standardised management system.
In order to ensure the accurate detection and comprehensive control of product quality.
In 2010, the company's vitamin B1 (vitamin B1) API passed the GMP certification of Jiangsu Food and Drug Administration of China
Obtained the new GMP certification certificate in November 2016
Registration number obtained in 2019 (Y20190009775)
December 12, 2013 Mesalazine issued a certificate for the export of EU APIs
Obtained EU CEP certificate on March 20, 2014
Successful renewal of licenses in 2019
Application for renewal of production license in 2020 has been approved, valid until December 16, 2025
2011 ~ Now